Royalty Pharma annual operating expenses
2018
2020
2021
2022
2023
2024
2025
Royalty Pharma Operating Expenses Growth & History (RPRX)
Royalty Pharma's operating expenses was $818.7M for fiscal 2025.
View full Royalty Pharma company overviewRoyalty Pharma annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $818.7M | −$152.5M | −15.70% |
| 2024 | 2024-12-31 | $971.1M | $108.7M | +12.61% |
| 2023 | 2023-12-31 | $862.4M | −$1.07B | −55.32% |
| 2022 | 2022-12-31 | $1.93B | $1.07B | +124.76% |
| 2021 | 2021-12-31 | $858.7M | $331.8M | +62.96% |
| 2020 | 2020-12-31 | $527.0M | — | — |
| 2018 | 2018-12-31 | $430.4M | — | — |
Royalty Pharma quarterly operating expenses
Q2.19
Q1.20
Q2.20
Q3.20
Q1.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $541.0M | $172.2M | +46.67% |
| Q1 2026 | 2026-03-31 | $67.5M | $33.5M | +98.26% |
| Q4 2025 | 2025-12-31 | $233.6M | — | — |
| Q3 2025 | 2025-09-30 | $182.1M | — | — |
| Q2 2025 | 2025-06-30 | $368.9M | $101.2M | +37.82% |
| Q1 2025 | 2025-03-31 | $34.1M | −$607.7M | −94.69% |
| Q2 2024 | 2024-06-30 | $267.6M | −$21.7M | −7.51% |
| Q1 2024 | 2024-03-31 | $641.8M | $436.8M | +213.05% |
| Q3 2023 | 2023-09-30 | $384.9M | $3.6M | +0.95% |
| Q2 2023 | 2023-06-30 | $289.4M | $131.2M | +82.95% |
| Q1 2023 | 2023-03-31 | $205.0M | −$137.3M | −40.12% |
| Q4 2022 | 2022-12-31 | $1.05B | — | — |
| Q3 2022 | 2022-09-30 | $381.3M | $98.5M | +34.85% |
| Q2 2022 | 2022-06-30 | $158.2M | — | — |
| Q1 2022 | 2022-03-31 | $342.3M | −$1.4M | −0.41% |
| Q3 2021 | 2021-09-30 | $282.7M | $254.9M | +915.81% |
| Q1 2021 | 2021-03-31 | $343.7M | $204.3M | +146.49% |
| Q3 2020 | 2020-09-30 | $27.8M | — | — |
| Q2 2020 · Jun 30 | 2020-06-30 | $101.6M | −$28.2M | −21.71% |
| Q1 2020 | 2020-03-31 | $139.4M | — | — |
| Q2 2019 | 2019-06-30 | $129.7M | — | — |
Royalty Pharma operating expenses trends
Over the last five fiscal years, Royalty Pharma's operating expenses increased from $527.0M to $818.7M, a change of $291.7M. The latest reported quarter, Q2 2026, shows $541.0M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Royalty Pharma source filings ↗